Sheldon W. Tobe

22.0k total citations · 4 hit papers
184 papers, 6.8k citations indexed

About

Sheldon W. Tobe is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Sheldon W. Tobe has authored 184 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Cardiology and Cardiovascular Medicine, 42 papers in Nephrology and 34 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Sheldon W. Tobe's work include Blood Pressure and Hypertension Studies (89 papers), Dialysis and Renal Disease Management (20 papers) and Sodium Intake and Health (19 papers). Sheldon W. Tobe is often cited by papers focused on Blood Pressure and Hypertension Studies (89 papers), Dialysis and Renal Disease Management (20 papers) and Sodium Intake and Health (19 papers). Sheldon W. Tobe collaborates with scholars based in Canada, United States and United Kingdom. Sheldon W. Tobe's co-authors include Janusz Kaczorowski, Ellen Burgess, Euan Carlisle, Johannes F.E. Mann, David C. Mendelssohn, Brendan J. Barrett, Ognjenka Djurdjev, Jean Éthier, Christopher Thompson and Martin G. Myers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Sheldon W. Tobe

183 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

2021 657 citations Alfred K. Cheung, Tara I. Chang et al. profile →
Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin

1999 653 citations Adeera Levin, Christopher Thompson et al. American Journal of Kidney Diseases profile →
The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis

2017 314 citations Sheldon W. Tobe et al. profile →
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

2021 176 citations Alfred K. Cheung, Tara I. Chang et al. profile →

Peers

Countries citing papers authored by Sheldon W. Tobe

Since Specialization

Citations

This map shows the geographic impact of Sheldon W. Tobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon W. Tobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon W. Tobe more than expected).

Fields of papers citing papers by Sheldon W. Tobe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheldon W. Tobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon W. Tobe. The network helps show where Sheldon W. Tobe may publish in the future.

Co-authorship network of co-authors of Sheldon W. Tobe

This figure shows the co-authorship network connecting the top 25 collaborators of Sheldon W. Tobe. A scholar is included among the top collaborators of Sheldon W. Tobe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheldon W. Tobe. Sheldon W. Tobe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chronic Kidney Disease in Diabetes: A Clinical Practice Guideline 2025 ·Canadian Journal of Diabetes ·Sheldon W. Tobe, Harpreet S. Bajaj, Navdeep Tangri, Rahul Jain, (unknown), (unknown), Phil McFarlane	2
2	Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Canada 2024 ·Journal of Medical Economics ·Phil McFarlane, Mina Madan, (unknown), Sheldon W. Tobe, Ernesto L. Schiffrin, Raj Padwal, Ross D. Feldman, George K. Dresser, Lindsay Machan, (unknown), (unknown), Jan B. Pietzsch	1
3	Fibromuscular Dysplasia: A Focused Review for the Cardiologist 2024 ·CJC Open ·(unknown), Anita Shah, Andrew Dueck, Christine Hawkes, Sheldon W. Tobe, (unknown), Mina Madan	2
4	COST-EFFECTIVENESS OF RADIOFREQUENCY RENAL DENERVATION FOR TREATMENT OF UNCONTROLLED HYPERTENSION: A CANADIAN PERSPECTIVE 2023 ·Canadian Journal of Diabetes ·Ross D. Feldman, (unknown), (unknown), (unknown), Sheldon W. Tobe, Ernesto L. Schiffrin, Raj Padwal, Lindsay Machan, Jan B. Pietzsch	1
5	COST-EFFECTIVENESS OF RADIOFREQUENCY RENAL DENERVATION FOR TREATMENT OF UNCONTROLLED HYPERTENSION: A CANADIAN PERSPECTIVE 2023 ·Canadian Journal of Cardiology ·Ross D. Feldman, (unknown), (unknown), (unknown), Sheldon W. Tobe, Ernesto L. Schiffrin, Raj Padwal, Lindsay Machan, Jan B. Pietzsch	1
6	Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline 2021 ·Annals of Internal Medicine ·Charles Tomson, Alfred K. Cheung, Johannes F.E. Mann, Tara I. Chang, William C. Cushman, Susan L. Furth, Fan Fan Hou, Greg Knoll, Paul Muntner, Roberto Pecoits‐Filho, Sheldon W. Tobe, Lyubov Lytvyn, Jonathan C. Craig, David J. Tunnicliffe, Martin Howell, Marcello Tonelli, Michael Cheung, Amy Earley, Joachim H. Ix, Mark J. Sarnak	36
7	Randomized Controlled Trial Comparing Automated Office Blood Pressure Readings After Zero or Five Minutes of Rest 2021 ·Hypertension ·Sheldon W. Tobe, (unknown), (unknown), (unknown), Martin G. Myers	9
8	A retrospective observational population‐based study to assess the prevalence and burden of illness of type 2 diabetes with an estimated glomerular filtration rate < 90 mL/min/1.73 m ² in Ontario, Canada 2020 ·Diabetes Obesity and Metabolism ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sheldon W. Tobe, Jennifer B. Rose	5
9	Hypertension Canada’s 2020 Evidence Review and Guidelines for the Management of Resistant Hypertension 2020 ·Canadian Journal of Cardiology ·Swapnil Hiremath, Ruth Sapir‐Pichhadze, Meranda Nakhla, Jonathan Y. Gabor, Nadia Khan, Laura M. Kuyper, Marcel Ruzicka, Sheldon W. Tobe, Karen C. Tran, Doreen M. Rabi, Stella S. Daskalopoulou	32
10	Comparison of Readmission and Death Among Patients With Cardiac Disease in Northern vs Southern Ontario 2019 ·Canadian Journal of Cardiology ·(unknown), (unknown), Peter C. Austin, Heather J. Ross, Husam Abdel‐Qadir, Harindra C. Wijeysundera, Karen Tu, Peter Cram, Peter P. Liu, Howard Abrams, Jacob A. Udell, Susanna Mak, Michael E. Farkouh, Jack V. Tu, Xuesong Wang, Sheldon W. Tobe, Douglas S. Lee	8
11	Measuring Cardiovascular Quality in Primary Care Using Canadian Cardiovascular Harmonization of National Guidelines Endeavour and Electronic Medical Record Data in Ontario 2018 ·CJC Open ·(unknown), Sheldon W. Tobe, Debra A. Butt, Noah Ivers, Liisa Jaakkimainen, Peter Liu, (unknown), Karen Tu	1
12	Steady-State Pharmacokinetics of Oral Ciprofloxacin in Continuous Cycling Peritoneal Dialysis Patients: Brief Report 2018 ·Peritoneal Dialysis International ·Colin Lee, Sandra A N Walker, (unknown), Lesley Palmay, Scott E. Walker, Sheldon W. Tobe, Andrew E. Simor	3
13	The Global Alliance for Chronic Diseases Supports 15 Major Studies in Hypertension Prevention and Control in Low‐ and Middle‐Income Countries 2016 ·Journal of Clinical Hypertension ·Sheldon W. Tobe	8
14	Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD 2014 ·American Journal of Kidney Diseases ·Marcel Ruzicka, Robert R. Quinn, Phil McFarlane, Brenda R. Hemmelgarn, G. V. Ramesh Prasad, Janusz Feber, Gihad Nesrallah, Martin MacKinnon, Navdeep Tangri, Brendan McCormick, Sheldon W. Tobe, Tom Blydt‐Hansen, Swapnil Hiremath	25
15	β-Adrenergic Receptor Blockers in Hypertension 2014 ·Canadian Journal of Cardiology ·Sheldon W. Tobe	5
16	Risks and benefits of intensive blood pressure lowering in patients with type 2 diabetes 2013 ·Canadian Medical Association Journal ·Doreen M. Rabi, Raj Padwal, Sheldon W. Tobe, Richard E. Gilbert, Lawrence A. Leiter, Robert R. Quinn, Nadia Khan	14
17	Valve Replacement Surgery Complicated by Acute Renal Failure-Predictors of Early Mortality 2006 ·Journal of Cardiac Surgery ·Sheldon W. Tobe	1
18	The Effect of Alcohol and Gender on Ambulatory Blood Pressure: Results From the Baseline Double Exposure Study 2006 ·American Journal of Hypertension ·Sheldon W. Tobe, (unknown), A KISS, Nancy Perkins, Brian Baker	13
19	Update on calcium antagonists and the kidney 2003 ·Current Opinion in Nephrology & Hypertension ·Sheldon W. Tobe	9
20	Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin breakdown → 1999 ·American Journal of Kidney Diseases ·Adeera Levin, Christopher Thompson, Jean Éthier, Euan Carlisle, Sheldon W. Tobe, David C. Mendelssohn, Ellen Burgess, Kailash Jindal, Brendan J. Barrett, Joel Singer, Ognjenka Djurdjev	653

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact